Delivery Order 36C25222D0031-36C25223N0337
- Not listed
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $202,467.88, is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, which are radioactive isotopes used in nuclear medicine and diagnostic imaging. The contract has a ceiling value of $407,578.50 and is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of March 31, 2025. This award is not set aside for...
- This is a Delivery Order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., under an Indefinite Delivery Vehicle (IDV) contract with the Department of Veterans Affairs (VA). The contract, valued at $179,778.00, is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers. Cardinal...
- This $80,260 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This contract is not set aside for any specific...
- This is a firm-fixed-price delivery order contract awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The contract has a potential value of $406,942.11 and covers the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well...
- This is a delivery order contract awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals and related products to the Department of Veterans Affairs (VA). The contract has a ceiling value of $7,003,801.26 and a performance period through March 31, 2024. Cardinal Health 414 is a major supplier of nuclear medicine products and services to federal healthcare agencies, including the VA, Department of Defense, and National Institutes of...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The $916,372.58 contract is for the delivery of radiopharmaceuticals, which are radioactive drugs used for diagnostic imaging and cancer treatment. Cardinal Health 414 has several indefinite delivery vehicle (IDV) contracts with the VA, Department of Defense, and National Institutes of Health to...
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of nuclear medicine radiopharmaceuticals, including isotopes such as technetium-99m, iodine-123, and fluorine-18 FDG, to VA medical centers, military treatment facilities, and National Institutes of Health (NIH) research centers nationwide. The contract is a delivery order with a firm fixed price of $163,589.48 and...
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, which are radioactive pharmaceuticals used in nuclear medicine, oncology, and diagnostic imaging. The contract has a ceiling value of $229,022.00 and is a firm fixed price contract. The contract is not a set-aside. Cardinal Health 414 has been awarded multiple Indefinite...
- 36C25222D0031Indefinite Delivery Contract
- 36C25222D0031-36C25223N0337Delivery Order
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $127,107.03 and a period of performance through March 31, 2027. Cardinal Health 414 holds multiple Indefinite Delivery Vehicle (IDV) contracts with the VA, Department of Defense, and National Institutes of Health to support their nuclear medicine programs, with individual IDV values ranging from approximately $1 million to $39.8 million. This contract was not set aside for any specific business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($12k) | 8/14/24 | |
| Not listed | Not listed | $139.6k | 3/13/23 |